BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 884122)

  • 1. Purification of neuraminidase from influenza viruses by affinity chromatography.
    Bucher DJ
    Biochim Biophys Acta; 1977 Jun; 482(2):393-9. PubMed ID: 884122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2 (N2) neuraminidase of the X-7 influenza virus recombinant: determination of molecular size and subunit composition of the active unit.
    Bucher DJ; Kilbourne ED
    J Virol; 1972 Jul; 10(1):60-6. PubMed ID: 5040386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of influenza virus neuraminidases: peptide changes associated with antigenic divergence between early and late N2 neuraminidases.
    Kendal AP; Kiley MP
    J Virol; 1973 Dec; 12(6):1482-90. PubMed ID: 4761727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of influenza virus neuraminidase with hemagglutinin activity and its comparison with that of viral neuraminidase.
    Arora DJ; Gabriel LF
    Biochim Biophys Acta; 1986 Oct; 884(1):73-83. PubMed ID: 3533157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypeptide composition of Influenza B viruses and enzymes associated with the purified virus particles.
    Oxford JS
    J Virol; 1973 Oct; 12(4):827-35. PubMed ID: 4359955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity chromatography of influenza virus on immobilized alpha- and beta-ketosides of neuraminic acid derivatives.
    Holmquist L; Nilsson G
    Acta Pathol Microbiol Scand B; 1979 Apr; 87B(2):129-35. PubMed ID: 443048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorometric assay for the measurement of viral neuraminidase in influenza vaccines.
    Lambré CR; Chauvaux S; Pilatte Y
    Vaccine; 1989 Apr; 7(2):104-5. PubMed ID: 2750267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):81-91. PubMed ID: 1029759
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the antigenicity of influenza virus neuraminidases due to various methods of preparation].
    Desselberger U
    Fortschr Med; 1978 Mar; 96(9):471-6. PubMed ID: 627393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behaviour of several influenza A2 virus strain neuraminidases after pronase treatment.
    Ionescu L; Handrache L; Alexandrescu M; Moroşanu V; Vancea G; Colev A
    Rev Roum Virol (1972); 1973; 10(3):209-12. PubMed ID: 4775622
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification and characterization of neuraminidase from Clostridium perfringens.
    Chien CH; Chang SC; Wei YH
    Proc Natl Sci Counc Repub China B; 1989 Jul; 13(3):201-9. PubMed ID: 2556722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of immunogenic neuraminidases of human influenza viruses by a combination of genetic and biochemical procedures.
    Gallagher M; Bucher DJ; Dourmashkin R; Davis JF; Rosenn G; Kilbourne ED
    J Clin Microbiol; 1984 Jul; 20(1):89-93. PubMed ID: 6205018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and partial characterization of neuraminidase from type III group B streptococci.
    Milligan TW; Mattingly SJ; Straus DC
    J Bacteriol; 1980 Oct; 144(1):164-71. PubMed ID: 6998945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase from influenza virus A (H3N2): specificity towards several substrates and procedure of activity determination.
    Cabezas JA; Calvo P; Eid P; Martin J; Perez E; Reglero A; Hannoun C
    Biochim Biophys Acta; 1980 Dec; 616(2):228-38. PubMed ID: 7213637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isolation of preparative amounts of influenza virus neuraminidase by affinity chromatography].
    Kharitonenkov IG; Zakomyrdin IuA; Elizarova GV
    Vopr Virusol; 1982; 27(2):184-9. PubMed ID: 7090345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionation of the influenza virus with the object of producing subunit vaccine.
    Hoyle L; Barker SM
    Postgrad Med J; 1973 Mar; 49(569):193-4. PubMed ID: 4802482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of viral neuraminidase from inclusion bodies produced by recombinant Escherichia coli.
    Lipničanová S; Chmelová D; Godány A; Ondrejovič M; Miertuš S
    J Biotechnol; 2020 Jun; 316():27-34. PubMed ID: 32302655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of a neuraminidase from Streptococcus K 6646.
    Kiyohara T; Terao T; Shioiri-Nakano K; Osawa T
    Arch Biochem Biophys; 1974 Oct; 164(2):575-82. PubMed ID: 4460881
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural and composition of the N2 neuraminidase of influenza virus. Effect of carbohydrate content on the validity of molecular weight estimations.
    Groome NP; Belyavin G; Lansdell A; Ashford D
    Biochim Biophys Acta; 1977 Nov; 495(1):58-70. PubMed ID: 911884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Ca++ on the stability of influenza virus neuraminidase.
    Baker NJ; Gandhi SS
    Arch Virol; 1976; 52(1-2):7-18. PubMed ID: 63277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.